[Imeglimin: features of the mechanism of action and potential benefits].
Kuznetsov KO, Saetova AA, Mahmutova EI, Bobrik AG, Bobrik DV, Nagaev IR, Khamitova AD, Arapieva AM.
Kuznetsov KO, et al. Among authors: khamitova ad.
Probl Endokrinol (Mosk). 2022 Mar 11;68(3):57-66. doi: 10.14341/probl12868.
Probl Endokrinol (Mosk). 2022.
PMID: 35841169
Free PMC article.
Russian.